ClearMed
BriefingsDrug & Biomarker IndexSaved (0)
All Endocrinology BriefingsCell Metabolism
EndocrinologyReal-World Cohort3 min read

Lactate charging of tRNAs "brakes" the ribosome

Lactate has been recast from a waste product to a fuel and signaling molecule, yet why aggressive tumors invest so heavily in exporting it has remained unexplained.

Published in Cell MetabolismObservational cohort study
3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Source

Real-World Observation

3/5

In a recent study in Molecular Cell, Wang et al. show that upon excess lactate production, AARS1 charges lactate onto tRNAs, generating dead-end lactyl-tRNAs that obstruct translation elongation to re-balance metabolism, a molecular "brake" that cancer cells avoid through upregulation of lactate exporters.

What Changes?

Endocrinology · Real-World Cohort

Current Standard

Conventional endocrinology practice relies on standard-of-care monitoring and existing regimens prior to this observational cohort study.

New Finding

Published in Cell metabolism, these peer-reviewed endocrinology findings provide quantitative evidence to inform clinical risk stratification, therapeutic decision-making, and follow-up trial design.

3 Key Takeaways

Plain English Summary
  1. 01Core Finding

    Delivered via lactate charging of tRNAs "brakes" the ribosome, this real-world cohort approach targets Hormonal, glycemic & metabolic receptor signaling.

  2. 02Study Evidence

    Tested in a observational cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

What This Means for You

Published in Cell metabolism, these peer-reviewed endocrinology findings provide quantitative evidence to inform clinical risk stratification, therapeutic decision-making, and follow-up trial design.

The Discovery

Lactate has been recast from a waste product to a fuel and signaling molecule, yet why aggressive tumors invest so heavily in exporting it has remained unexplained. In a recent study in Molecular Cell, Wang et al. show that upon excess lactate production, AARS1 charges lactate onto tRNAs, generating dead-end lactyl-tRNAs that obstruct translation elongation to re-balance metabolism, a molecular "brake" that cancer cells avoid through upregulation of lactate exporters.

How It Works, Simply

This endocrinology research focuses on hormonal, glycemic & metabolic receptor signaling. Researchers evaluated it using an observational cohort study at the real-world cohort stage of medical research.

3 Key Takeaways

Clinical Takeaways
  1. 01Core Finding

    Delivered via lactate charging of tRNAs "brakes" the ribosome, this real-world cohort approach targets Hormonal, glycemic & metabolic receptor signaling.

  2. 02Study Evidence

    Tested in a observational cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

01

Biological Mechanism & Study Design

Study Design & Cohort

Observational cohort study

Observational cohort study · Real-World Cohort

Biological Pathway & Modality

Hormonal, glycemic & metabolic receptor signaling

Intervention: Lactate charging of tRNAs "brakes" the ribosome

02

Experimental Findings & Endpoints

Lactate has been recast from a waste product to a fuel and signaling molecule, yet why aggressive tumors invest so heavily in exporting it has remained unexplained.

In a recent study in Molecular Cell, Wang et al. show that upon excess lactate production, AARS1 charges lactate onto tRNAs, generating dead-end lactyl-tRNAs that obstruct translation elongation to re-balance metabolism, a molecular "brake" that cancer cells avoid through upregulation of lactate exporters.

03

Clinical Translation & Practice Context

Published in Cell metabolism, these peer-reviewed endocrinology findings provide quantitative evidence to inform clinical risk stratification, therapeutic decision-making, and follow-up trial design.

03

The Bottom Line · Clinical Pearl

“In a recent study in Molecular Cell, Wang et al. show that upon excess lactate production, AARS1 charges lactate onto tRNAs, generating dead-end lactyl-tRNAs that obstruct translation elongation to re-balance metabolism, a molecular "brake" that cancer cells avoid through upregulation of lactate exporters.”

Published in Cell Metabolism · Current Stage: Real-World Cohort

Endocrinology · Real-World Cohort
Study Type
Observational cohort study

Observational cohort study

Evidence Score
3/5 · Real-World Observation
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Who It Applies To
Observational cohort study in endocrinology care
Intervention & Mechanism
Lactate charging of tRNAs "brakes" the ribosome

Hormonal, glycemic & metabolic receptor signaling

Key Limitation
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

Translational Stage

LEVEL 2 · Real-World Cohort

Classified as Observational cohort study along the clinical evidence continuum

  1. Lab & Discovery
  2. Early Trials
  3. Human Evidence
  4. 4Real-World CohortActive

Original Publication & AMA Citation

Lactate charging of tRNAs "brakes" the ribosome. Cell Metabolism. Published 2026;Nov 3. Accessed November 15, 2026. https://pubmed.ncbi.nlm.nih.gov/42976770/

Cell Metabolism

https://pubmed.ncbi.nlm.nih.gov/42976770/

Read Original Paper

Continue Reading

Related in Endocrinology

View all Endocrinology briefings →
ENDOCRINOLOGY · CLINICAL PRACTICE

Ozempic in Pregnancy: Diabetes, Not Drug, Linked to Early Births?

The reason you're taking Ozempic or Wegovy matters during pregnancy, with underlying diabetes potentially posing a greater risk than the medication itself. This study challenges the previously held, often generalized, assumption that GLP-1 medications alone are responsible for pregnancy complications.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDaily
ENDOCRINOLOGY · REAL-WORLD COHORT

Clinical Guidance for Disease-Modifying Immunotherapy in Children and Adolescents With New-Onset (Stage 3) Type 1 Diabetes

Teplizumab-specific recommendations are identified, with broader principles framed for adaptation across health systems. This article addresses who should lead care, how to approach eligibility and timing, how to assess β-cell reserve and infection risk, how to sequence treatment with diabetic ketoacidosis recovery and early education, and how to monitor treatment safely.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readDiabetes Care
ENDOCRINOLOGY · REAL-WORLD COHORT

Transient Cognitive Vulnerability After Hypoglycemia in Adults With Type 1 Diabetes: Evidence From Continuous Glucose Monitoring and Cognitive Ecologic Momentary Assessment

Hypoglycemia was associated with a transient period of cognitive vulnerability largely confined to the hour after an event, with little evidence of delayed effects. Findings support avoiding or exercising caution during cognitively demanding tasks for up to an hour after a hypoglycemic event.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readDiabetes Care